Analyze Diet

Topic:NSAID

Non-steroidal anti-inflammatory drugs (NSAIDs) are a class of medications commonly used in horses to manage pain and inflammation. These drugs work by inhibiting enzymes involved in the inflammatory process, specifically cyclooxygenase (COX) enzymes, which play a role in the production of prostaglandins. NSAIDs are frequently administered for conditions such as musculoskeletal disorders, colic, and post-surgical pain. Common NSAIDs used in equine medicine include phenylbutazone, flunixin meglumine, and ketoprofen. While effective, the use of NSAIDs in horses requires careful management due to potential side effects, such as gastrointestinal ulceration and renal impairment. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacology, therapeutic applications, and safety considerations of NSAIDs in equine practice.
Adverse reactions to drugs.
In practice    September 1, 1983   Volume 5, Issue 5 174-180 doi: 10.1136/inpract.5.5.174
Keen P, Livingston A.No abstract available
Renal papillary necrosis in horses after phenylbutazone and water deprivation.
Veterinary pathology    September 1, 1983   Volume 20, Issue 5 603-610 doi: 10.1177/030098588302000512
Gunson DE, Soma LR.Acute renal papillary necrosis occurred in five horses given normal therapeutic doses of phenylbutazone and deprived of water for 36 to 48 hours prior to euthanasia. Five horses given phenylbutazone alone and four horses subjected to water deprivation alone did not develop papillary necrosis. Urinalyses were normal prior to water deprivation, and also after water deprivation in the horses that did not receive phenylbutazone, but the water-deprived, phenylbutazone-treated horses had many red blood cells, transitional epithelial cells, and large numbers of oxalate crystals in their urine. Ulcera...
Clinical efficacy of a revised dosage schedule of phenylbutazone in horses.
The Veterinary record    August 20, 1983   Volume 113, Issue 8 183-184 doi: 10.1136/vr.113.8.183
Taylor JB, Verrall JH, Chandler N, Jones RD, Parker J.No abstract available
Phenylbutazone toxicosis in the foal.
American journal of veterinary research    August 1, 1983   Volume 44, Issue 8 1410-1418 
Traub JL, Gallina AM, Grant BD, Reed SM, Gavin PR, Paulsen LM.No abstract available
Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses.
The Veterinary record    June 25, 1983   Volume 112, Issue 26 599-602 doi: 10.1136/vr.112.26.599
Taylor JB, Walland A, Lees P, Gerring EL, Maitho TE, Millar JD.Five pairs of matched horses were used to study the biochemical and haematological effects of a revised dosage schedule of phenylbutazone. One group of five horses received a phenylbutazone paste formulation daily for 12 days and a second group of five animals received a placebo preparation for a similar time. Some statistically significant differences were recorded from pretreatment levels in both groups of horses. These changes represented instability in baseline levels and could not be ascribed to phenylbutazone administration.
Effects of large doses of phenylbutazone administration to horses.
American journal of veterinary research    May 1, 1983   Volume 44, Issue 5 774-780 
MacKay RJ, French TW, Nguyen HT, Mayhew IG.The effects of large doses of phenylbutazone were evaluated in clinically normal horses. The drug was given to 4 groups of 2 horses each at the rate of 30 mg/kg of body weight, orally, or 30, 15, or 8 mg/kg IV daily for up to 2 weeks. All horses became anorectic and depressed after 2 to 4 phenylbutazone treatments, and the horses given 15 or 30 mg/kg died on or between days 4 and 7 of treatment. A decrease in total blood neutrophil count occurred in all horses, and was associated with toxic left shift in horses given the 2 larger dosage schedules. The horses also had progressive increases in s...
The metabolism of fenclofenac in the horse.
Xenobiotica; the fate of foreign compounds in biological systems    April 1, 1983   Volume 13, Issue 4 233-240 doi: 10.3109/00498258309052259
Marsh MV, Caldwell J, Sloan TP, Smith RL, Horner M, Moss MS.14C-Fenclofenac (2-(2'-4'-dichlorophenoxy)-phenylacetic acid) was administered orally to horses, and urinary metabolites investigated by chromatography. Fenclofenac was rapidly absorbed and eliminated, with a plasma half-life (t1/2) of 2.3 h, with 83.2 and 85.8% of the dose being recovered in the urine in 0-24 h. The major urinary metabolite was the ester glucuronide (58.8, 70.0% dose), and evidence is presented that this metabolite undergoes a structural rearrangement to give beta-glucuronidase-resistant isomers. The other 14C-labelled components in horse urine were unchanged fenclofenac (13....
Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
Canadian journal of comparative medicine : Revue canadienne de medecine comparee    April 1, 1983   Volume 47, Issue 2 172-179 
Johnstone IB.Nonsteroidal anti-inflammatory drugs are commonly used in the treatment of inflammatory conditions, and have potential value in the treatment of thrombotic disease in the horse. This study compares the potency of three nonsteroidal anti-inflammatory drugs phenylbutazone, naproxen (equiproxen) and flunixin meglumine (banamine) with respect to their effects on equine platelets. Two functional responses of horse platelets were evaluated in vitro: their ability to aggregate and their ability to make available platelet factor 3 procoagulant activity. Flunixin at a concentration of 10(-6) M signific...
From firing to phenylbutazone in equine practice.
The Veterinary record    December 4, 1982   Volume 111, Issue 23 523-525 
Vogel C.No abstract available
Paste formulation of phenylbutazone.
The Veterinary record    October 9, 1982   Volume 111, Issue 15 353 doi: 10.1136/vr.111.15.353-a
Snow DH.No abstract available
Equine immunology 3: immunopharmacology–anti-inflammatory and antihypersensitivity drugs.
Equine veterinary journal    October 1, 1982   Volume 14, Issue 4 277-281 doi: 10.1111/j.2042-3306.1982.tb02424.x
Eyre P, Hanna CJ, Wells PW, McBeath DG.This article reviews anti-inflammatory and antihypersensitivity drugs under these 4 headings: Functional or physiological antagonists; Selective pharmacological inhibitors; Broad spectrum anti-inflammatory drugs; Miscellaneous inhibitors. The compounds considered include sympathomimetic amines, anticholinergic drugs, antihistamine drugs, tryptamine antagonists and dopamine antagonists, glucocorticosteroids and non-steroidal anti-inflammatory drugs, disodium cromoglycate and diethylcarbamazine citrate. The relationship of the pharmacological actions of these compounds is considered in the conte...
Phenylbutazone in the horse.
The Veterinary record    June 26, 1982   Volume 110, Issue 26 617 doi: 10.1136/vr.110.26.617-a
Lees P, Maitho E, Taylor JB.No abstract available
Factors affecting absorption of non-steroidal anti-inflammatory agents in the horse.
The Veterinary record    June 12, 1982   Volume 110, Issue 24 554-558 doi: 10.1136/vr.110.24.554
Sullivan M, Snow DH.The absorption of orally administered phenylbutazone (5 mg/kg) was studied in 10 thoroughbreds, eight ponies and four pony foals. Large variations in area under the curve (AUC) and peak plasma concentrations were found both within an animal and within groups of animals. Administration of phenylbutazone (5 mg/kg) following an overnight fast resulted in no difference among the three groups of animals with respect to AUC (0 to 24 hours), mean (+/- sd) values of which were 132 +/- 68, 107 +/- 48 and 98 +/- 6, respectively. Absorption characteristics of two oral phenylbutazone preparations (Equipal...
Use of phenylbutazone in horses and ponies.
The Veterinary record    April 17, 1982   Volume 110, Issue 16 389 doi: 10.1136/vr.110.16.389
Chandler N.No abstract available
Phenylbutazone in ponies.
The Veterinary record    April 10, 1982   Volume 110, Issue 15 365 doi: 10.1136/vr.110.15.365
Michell AR, Lees P, Millar JD.No abstract available
Adverse effects of indomethacin in the horse.
Journal of veterinary pharmacology and therapeutics    March 1, 1982   Volume 5, Issue 1 83-86 doi: 10.1111/j.1365-2885.1982.tb00501.x
Roberts MC.No abstract available
Stifle lameness in the horse: a survey of 86 referred cases.
Equine veterinary journal    January 1, 1982   Volume 14, Issue 1 31-39 doi: 10.1111/j.2042-3306.1982.tb02331.x
Jeffcott LB, Kold SE.The clinical and radiological characteristics of stifle lameness in 86 horses are described. The majority of these cases had been lame for some weeks before referral. The most frequent diagnoses made were osteochondrosis dissecans (13 per cent) and subchondral bone cyst (38 per cent). Both of these conditions were seen principally in Thoroughbreds at or before the onset of training. The other bone lesions encountered were osteoarthritis (3 per cent), fractures (4 per cent) and "epiphysitis" (1 per cent). The commonest soft tissue condition was an atypical or partial upward fixation of the pate...
Non-steroidal anti-inflammatory agents in the horse.
In practice    September 1, 1981   Volume 3, Issue 5 24-31 doi: 10.1136/inpract.3.5.24
Snow D.No abstract available
Analysis of phenylbutazone and its metabolites by high performance liquid chromatography.
Equine veterinary journal    July 1, 1981   Volume 13, Issue 3 201-203 doi: 10.1111/j.2042-3306.1981.tb03489.x
Taylor JB, Lees P, Gerring EL.No abstract available
Effect of oral administration of acetylsalicylic acid on haemostasis in the horse.
Equine veterinary journal    July 1, 1981   Volume 13, Issue 3 205-206 doi: 10.1111/j.2042-3306.1981.tb03491.x
Trujillo O, Rios A, Maldonado R, Rudolph W.No abstract available
Science and the administration of phenylbutazone.
Equine veterinary journal    July 1, 1981   Volume 13, Issue 3 144-145 doi: 10.1111/j.2042-3306.1981.tb03469.x
No abstract available
Endotoxaemia in the horse.
Equine veterinary journal    April 1, 1981   Volume 13, Issue 2 89-94 doi: 10.1111/j.2042-3306.1981.tb04120.x
Burrows GE.Endotoxins are non-protein fragments of the cell wall of Gram-negative bacteria. They must be absorbed into the circulation to produce disease and systemic effects are similar, regardless of bacterial source. Absorption of endotoxins occurs in obstructive bowel disease and may play a significant part in determining the severity of the disease. Many of the responses to experimentally administered endotoxin are identical to those of bowel diseases or the horse and include circulatory, haematological and metabolic alterations. Therapeutic approaches are indirect and include many drugs currently e...
Prevention of endotoxin-induced arterial hypoxaemia and lactic acidosis with flunixin meglumine in the conscious pony.
Equine veterinary journal    April 1, 1981   Volume 13, Issue 2 95-98 doi: 10.1111/j.2042-3306.1981.tb04122.x
Moore JN, Garner HE, Shapland JE, Hatfield DG.Bacterial endotoxin injected intravenously into conscious ponies produced alterations in cardiopulmonary and gastrointestinal function. Specifically, tachypnoea, dyspnoea, hypoxaemia, colic, lactic acidosis and diarrhoea resulted from administration of 10 micrograms/kg Escherichia coli endotoxin. Pretreatment of the ponies with a potent prostaglandin synthetase inhibitor, flunixin meglumine, prevented these ill effects of endotoxin.
Use of phenylbutazone in competitions.
The Veterinary record    March 21, 1981   Volume 108, Issue 12 248 doi: 10.1136/vr.108.12.248
Vogel C.No abstract available
Phenylbutazone toxicity in ponies.
The Veterinary record    January 19, 1980   Volume 106, Issue 3 68 doi: 10.1136/vr.106.3.68
Snow DH, Douglas TA, Thompson H, Parkins JJ, Holmes PH.No abstract available
Clinical pharmacology of salicylates.
Journal of the American Veterinary Medical Association    January 1, 1980   Volume 176, Issue 1 65-66 
Davis LE.No abstract available
A gas chromatographic screening procedure for the detection of non-steroidal anti-inflammatory drugs in horse urine.
Equine veterinary journal    October 1, 1979   Volume 11, Issue 4 259-263 doi: 10.1111/j.2042-3306.1979.tb01360.x
Hunt JP, Haywood PE, Moss MS.A gas chromatographic screening procedure for the non-steroidal anti-inflammatory group of drugs is described. The method invovles on-column methylation of the carboxylic acid group using trimethylanilinium hydroxide as the methylating reagent. Fifteen such drugs were studied. Eight of these were detected in urine collected from horses that had received these compounds orally and for these drugs, rates of urinary excretion are recorded. Seven other members of this group of drugs were shown to be detectable by this procedure but in these cases the drug was added to urine and not administered to...
Phenylbutazone toxicity in ponies.
The Veterinary record    August 18, 1979   Volume 105, Issue 7 150-151 doi: 10.1136/vr.105.7.150
Lees P, Michell AR.No abstract available
Phenylbutazone inhibition of equine platelet function.
American journal of veterinary research    February 1, 1979   Volume 40, Issue 2 265-270 
Meyers KM, Lindner C, Katz J, Grant B.Nonsteroidal anti-inflammatory drugs impair platelet aggregation and secretion in man, pigs, and rabbits and inhibit platelet thromboxane/prostaglandin synthesis. The present investigation studied the effects of phenylbutazone on platelet aggregation and bleeding times in the horse. Aggregation responses to adenosine diphosphate and collagen were markedly impaired 15 minutes and 2 hours after treatment, but 4 hours after treatment, platelet responses approximated those prior to treatment. The in vivo effect of phenylbutazone correlated with its plasma concentrations. Phenylbutazone, like aspir...
The use of phenylbutazone in the horse.
The Veterinary record    December 23, 1978   Volume 103, Issue 26-27 571 doi: 10.1136/vr.103.26-27.571
No abstract available